Heska HSKA Stock
Heska Price Chart
Heska HSKA Financial and Trading Overview
Heska stock price | 119.99 USD |
Previous Close | 119.99 USD |
Open | 119.96 USD |
Bid | 119.99 USD x 1400 |
Ask | 120 USD x 1300 |
Day's Range | 119.99 - 119.99 USD |
52 Week Range | 57.83 - 120.03 USD |
Volume | 330.89K USD |
Avg. Volume | 340.75K USD |
Market Cap | 1.31B USD |
Beta (5Y Monthly) | 1.599225 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | September 26, 2012 |
1y Target Est | 130 USD |
HSKA Valuation Measures
Enterprise Value | 1.29B USD |
Trailing P/E | N/A |
Forward P/E | 799.9333 |
PEG Ratio (5 yr expected) | -5.71 |
Price/Sales (ttm) | 5.1377344 |
Price/Book (mrq) | 3.1359277 |
Enterprise Value/Revenue | 5.078 |
Enterprise Value/EBITDA | -138.808 |
Trading Information
Heska Stock Price History
Beta (5Y Monthly) | 1.599225 |
52-Week Change | 42.45% |
S&P500 52-Week Change | 20.43% |
52 Week High | 120.03 USD |
52 Week Low | 57.83 USD |
50-Day Moving Average | 117.59 USD |
200-Day Moving Average | 87.26 USD |
HSKA Share Statistics
Avg. Volume (3 month) | 340.75K USD |
Avg. Daily Volume (10-Days) | 346.35K USD |
Shares Outstanding | 10.91M |
Float | 10.29M |
Short Ratio | 5.41 |
% Held by Insiders | 6.45% |
% Held by Institutions | 87.54% |
Shares Short | 1.32M |
Short % of Float | 16.75% |
Short % of Shares Outstanding | 12.06% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -7.85% |
Operating Margin (ttm) | -9.40% |
Gross Margin | 42.92% |
EBITDA Margin | -3.65% |
Management Effectiveness
Return on Assets (ttm) | -2.50% |
Return on Equity (ttm) | -4.73% |
Income Statement
Revenue (ttm) | 254.89M USD |
Revenue Per Share (ttm) | 24.57 USD |
Quarterly Revenue Growth (yoy) | -3.69% |
Gross Profit (ttm) | 111.17M USD |
EBITDA | -9324000 USD |
Net Income Avi to Common (ttm) | -20028000 USD |
Diluted EPS (ttm) | -1.92 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 125.21M USD |
Total Cash Per Share (mrq) | 11.47 USD |
Total Debt (mrq) | 109.92M USD |
Total Debt/Equity (mrq) | 26.32 USD |
Current Ratio (mrq) | 5.641 |
Book Value Per Share (mrq) | 38.263 |
Cash Flow Statement
Operating Cash Flow (ttm) | -13309000 USD |
Levered Free Cash Flow (ttm) | -5779625 USD |
Profile of Heska
Country | United States |
State | CO |
City | Loveland |
Address | 3760 Rocky Mountain Avenue |
ZIP | 80538 |
Phone | 970 493 7272 |
Website | https://www.heska.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 808 |
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.
Q&A For Heska Stock
What is a current HSKA stock price?
Heska HSKA stock price today per share is 119.99 USD.
How to purchase Heska stock?
You can buy HSKA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Heska?
The stock symbol or ticker of Heska is HSKA.
Which industry does the Heska company belong to?
The Heska industry is Medical Devices.
How many shares does Heska have in circulation?
The max supply of Heska shares is 10.91M.
What is Heska Price to Earnings Ratio (PE Ratio)?
Heska PE Ratio is 0.00000000 now.
What was Heska earnings per share over the trailing 12 months (TTM)?
Heska EPS is 0 USD over the trailing 12 months.
Which sector does the Heska company belong to?
The Heska sector is Healthcare.
Heska HSKA included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}